Neuronal genes deregulated in Cornelia de Lange Syndrome respond to removal and re-expression of cohesin.
Felix Daniel WeissLesly CalderonYi-Fang WangRadina GeorgievaYa GuoNevena CvetesicManinder KaurGopuraja DharmalingamIan D KrantzBoris LenhardAmanda G FisherMatthias MerkenschlagerPublished in: Nature communications (2021)
Cornelia de Lange Syndrome (CdLS) is a human developmental disorder caused by mutations that compromise the function of cohesin, a major regulator of 3D genome organization. Cognitive impairment is a universal and as yet unexplained feature of CdLS. We characterize the transcriptional profile of cortical neurons from CdLS patients and find deregulation of hundreds of genes enriched for neuronal functions related to synaptic transmission, signalling processes, learning and behaviour. Inducible proteolytic cleavage of cohesin disrupts 3D genome organization and transcriptional control in post-mitotic cortical mouse neurons, demonstrating that cohesin is continuously required for neuronal gene expression. The genes affected by acute depletion of cohesin belong to similar gene ontology classes and show significant numerical overlap with genes deregulated in CdLS. Interestingly, reconstitution of cohesin function largely rescues altered gene expression, including the expression of genes deregulated in CdLS.
Keyphrases
- genome wide
- gene expression
- genome wide identification
- dna methylation
- transcription factor
- bioinformatics analysis
- cognitive impairment
- poor prognosis
- genome wide analysis
- end stage renal disease
- endothelial cells
- ejection fraction
- spinal cord
- machine learning
- newly diagnosed
- liver failure
- case report
- cell proliferation
- binding protein
- chronic kidney disease
- peritoneal dialysis
- cerebral ischemia
- intensive care unit
- heat shock
- spinal cord injury
- respiratory failure
- extracorporeal membrane oxygenation
- patient reported
- brain injury
- patient reported outcomes
- subarachnoid hemorrhage